Adherence to antiemetic guidelines in patients with malignant glioma: a quality improvement project to translate evidence into practice

Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score

(2012) Andrea Tendas et al.   SUPPORTIVE CARE IN CANCER

The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life

(2012) Carole Farrell et al.   SUPPORTIVE CARE IN CANCER

A Systematic Review and Meta-Analysis of Intravenous Palonosetron in the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults

(2011) Z. Likun et al.   ONCOLOGIST

Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting

(2011) Henning Burmeister et al.   SUPPORTIVE CARE IN CANCER

Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study

(2010) Antonio Rozzi et al.   SUPPORTIVE CARE IN CANCER

Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis

(2010) Tobias Engel Ayer Botrel et al.   SUPPORTIVE CARE IN CANCER

Chemotherapy-Induced Nausea and Vomiting

(2008) Paul J. Hesketh   NEW ENGLAND JOURNAL OF MEDICINE

A review of patient self-report tools for chemotherapy-induced nausea and vomiting

(2008) Sarah G. Brearley et al.   SUPPORTIVE CARE IN CANCER